Mallet Research Brief

April 9, 202610 min read

The Complete Guide to GLP-1 Optimization: What Ozempic Users Should Actually Be Tracking

Up to 40% of weight lost on GLP-1 medications can be muscle. Here's the protocol for preserving lean mass — protein targets, supplement stack, training, and bloodwork.

GLP-1NutritionMuscle

Ozempic, Wegovy, Mounjaro, Zepbound. GLP-1 medications are the fastest-growing drug class in the history of medicine. Thirty million Americans are currently on one. Most of them are tracking the wrong thing.

The weight loss data on GLP-1 medications is real and well-established. What gets buried in the research (and is almost never discussed in the context of actual user experience) is the composition of that weight loss. Studies on semaglutide and tirzepatide consistently show that up to 40% of the weight lost on these medications comes from lean mass, not fat.

Read that again. For every 10 pounds you lose on a GLP-1, as many as four of those pounds may be muscle.

This is not a minor side effect. Lean mass is your metabolic engine. It determines your resting metabolism, your insulin sensitivity, your functional strength, and most critically for anyone thinking about long-term outcomes, your probability of keeping the weight off when the medication is eventually adjusted, paused, or discontinued.

The only way to know whether your lost pounds are fat or muscle is to measure body composition directly. A DEXA scan, tracked over time, settles the question the scale never can. See how to track lean mass on GLP-1 with DEXA for the full approach.

GLP-1 users don't need a weight loss app. They need a muscle preservation app.

Why Muscle Loss Is the Silent Risk

GLP-1 medications work by suppressing appetite. They make eating less effortless, which is why they work so well for weight loss. The problem is that “eating less” in practice often means eating substantially less protein than your body needs to maintain muscle. When calories drop sharply and resistance training is absent, you lose muscle alongside fat.

The consequences compound. Less muscle means a lower resting metabolism. A lower metabolism means the caloric deficit required to keep losing weight narrows over time. For users who eventually reduce their dose or discontinue (which happens for cost reasons, side effects, or simply reaching their goal), the lower muscle baseline makes fat regain significantly more likely. Muscle preservation is the primary way to avoid that rebound.

The Protein Targets That Actually Apply to GLP-1 Users

Standard protein recommendations for the general population sit around 0.6–0.8g per kilogram of bodyweight per day. Those numbers are not appropriate for GLP-1 users.

The research on muscle preservation during caloric restriction points to a minimum of 0.8–1.2g of protein per kilogram of bodyweight per day, with the higher end appropriate for users over 50, anyone with a resistance training program, and anyone whose muscle loss is already measurable.

Total daily protein matters, but there's a more important number: per-meal protein threshold. Each meal needs at least 2.5–3g of leucine (the specific amino acid that triggers the muscle-building signal) to meaningfully activate muscle protein synthesis. Below that threshold, the signal doesn't fire regardless of your daily total. In practice, this means at least 25–40g of high-quality protein per meal, spread across three to four meals, rather than hitting a daily number in one or two large servings.

For context: a chicken breast is roughly 25–30g of protein. A full-fat Greek yogurt with added whey hits the threshold comfortably. A protein shake made with quality whey isolate gets there in one serving.

The Supplement Stack for Muscle Preservation

Two supplements have the strongest evidence specifically for preserving lean mass during caloric restriction:

Creatine monohydrate: 3–5g daily. Creatine is the most studied supplement in exercise science. During caloric restriction and reduced training volume (both common on GLP-1 protocols), creatine supports energy recovery between sets, reduces markers of muscle breakdown, and has independent data on preserving lean mass during weight loss phases. The monohydrate form works as well as any proprietary formulation at a fraction of the cost. No loading phase required at 5g/day.

HMB (beta-hydroxy beta-methylbutyrate): 3g daily. HMB is a breakdown product of leucine with specific muscle-protective properties. It works differently from creatine: rather than supporting energy production, HMB directly blocks the protein breakdown pathways that activate during caloric restriction. The evidence is strongest in older populations and during periods of reduced food intake, which is exactly the context of GLP-1 therapy. Split into 1g doses across three meals for best absorption.

These two do not replace protein intake or resistance training. They support a protocol that already has both.

Resistance Training Is Non-Negotiable

This is the most important item in this article and the most frequently omitted from GLP-1 conversations.

Resistance training 2–3 times per week is mandatory for meaningful muscle preservation during GLP-1 therapy. Not optional, not supplementary. Mandatory. Protein and creatine create the conditions for muscle preservation. The physical stimulus from lifting is what actually uses those conditions.

The sessions don't need to be long. Full-body sessions of 45–60 minutes targeting major compound movements (squat, hinge, push, pull) are sufficient to preserve lean mass during a caloric deficit. What matters is consistency and progressive load, not volume.

Keep sessions under 60–75 minutes. Beyond that point, cortisol rises enough to start working against your muscle-building signal, which is a particular concern when you're already eating less than normal.

The Nutrition Strategies That Complement GLP-1 Therapy

Beyond protein targets, a few evidence-backed nutrition strategies are especially relevant for GLP-1 users:

Meal Sequencing

Eating protein, fat, and fiber before carbohydrates in a meal boosts natural GLP-1 secretion and reduces blood sugar spikes after eating by 30–40% in controlled trials. When you're already on a GLP-1, the blood sugar benefit is less critical, but the protein-first approach enforces adequate protein intake before appetite suppression kicks in. GLP-1 medications reduce how much you eat overall. If you're eating less, the quality of what you do eat becomes disproportionately important. Eat your protein first. Every meal.

Front-Loading Calories

Your body processes calories more efficiently earlier in the day. Studies show that making breakfast the largest meal and dinner the smallest reduces total daily caloric intake by about 300 calories without intentional restriction, on top of the appetite suppression already provided by GLP-1 medications. Practically: a protein-rich breakfast maintains satiety through the afternoon and ensures your protein targets are partially met before appetite suppression peaks later in the day.

Overnight Fasting Window

A 12–14 hour overnight fast (which most GLP-1 users are already achieving naturally given reduced appetite) supports metabolic flexibility by letting insulin return to baseline before the next meal. Adding a 3-hour gap between the last meal and bedtime preserves sleep-driven repair processes. This works alongside GLP-1 therapy rather than against it.

The Bloodwork You Should Actually Be Tracking

Most GLP-1 users track one number: body weight. Weight is misleading on these medications. Losing 40% of your weight from muscle won't necessarily show up as a meaningful change on a standard scale. You need metrics that can actually distinguish between fat loss and muscle loss.

MetricWhat to WatchWhy It Matters
Body compositionDEXA or bioimpedance, monthlyScale weight is useless without a fat vs. lean split
Fasting insulinTarget 2–5 µIU/mLConfirms metabolic improvement is real, not just caloric restriction
HbA1cLongevity target: 4.0–5.0%Tracks 3-month average blood sugar; confirms your metabolic response to the medication
Creatine kinase (CK)Trend, not absoluteRising CK can indicate muscle breakdown; context-dependent but useful to track
AlbuminShould stay stable or riseFalling albumin is an early sign of protein malnutrition. Catch it before muscle loss accelerates.
ApoBTarget <60 mg/dLGLP-1s improve lipid profiles; track ApoB specifically since LDL tells an incomplete story
hs-CRPTarget <1.0 mg/LReducing inflammation is a primary benefit of metabolic improvement; CRP should fall as your metabolic health improves

Retest every 3 months while on GLP-1 therapy. The goal is to confirm that the metabolic improvements are real and that lean mass is being preserved, not just that the scale is moving.

The Protocol in Summary

GLP-1 medications handle the appetite suppression. Your job is to build the protocol around them that preserves the muscle the medication is at risk of taking. That protocol has four non-negotiable pillars:

  1. 1
    Protein first, every meal.0.8–1.2g/kg/day minimum. 25–40g per meal to hit the leucine threshold. Don't let appetite suppression squeeze out protein intake.
  2. 2
    Resistance training, 2–3× per week.Compound movements, 45–60 minutes. This is the irreplaceable stimulus that preserves lean mass. Supplements support it; they do not replace it.
  3. 3
    Creatine 5g + HMB 3g daily.The two compounds with the strongest evidence for lean mass preservation during caloric restriction. Add them to the daily stack from day one.
  4. 4
    Track composition, not just weight.Monthly body composition check. Bloodwork every 3 months tracking fasting insulin, albumin, HbA1c, and ApoB. The scale is one data point. It's not the right one.

GLP-1 medications are genuinely effective tools. What they can't do (and were never designed to do) is tell you how to use them in the context of a full health protocol. That's what the research above is for.

Mallet has a dedicated GLP-1 protocol built around muscle preservation: protein targets adjusted to your bodyweight, a supplement stack with creatine and HMB pre-loaded, and bloodwork tracking that monitors albumin, fasting insulin, and ApoB over time. Your wearable data, training volume, and nutrition all feed into the same AI context, so the protocol adapts as your metrics change, not just when you remember to update something. Get early access →